Novo Nordisk Shares Fall as Trump Moves to Cut Price of Weight-Loss Drugs

Novo Nordisk's shares have taken a hit following President Trump's announcement to negotiate lower prices for weight-loss drugs. This move is significant as it could lead to reduced costs for Americans, but it raises concerns about the financial impact on the pharmaceutical company and its investors.